{"name":"Valo Health, Inc.","slug":"valo-health-inc","ticker":"","exchange":"","domain":"","description":"Valo Health, Inc. is a biotechnology company focused on developing innovative treatments for serious diseases. The company's pipeline includes two key drug candidates, with one in Phase 2 and another that has been discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNQ0EzVnVZYXNiV3RXb1ZqQTZhZ1FXNWh3R1VWeHM2VnRxZkFfNGtDOGZnYldGcXBjYXBwMVg2LWdtcjJGSXNEV3VnRmJLYkVXLXVYUHc4Q2RxQ1ZZOGh4OHAyNElsU1o2aFFYY3lVSktIbC1FY3BHNi1saG1mMFY1MU1ZMzVPNHdnTElLbUJjX2JWVHBVZE1KclJrcHRNVUdlRmc?oc=5","date":"2026-03-18","type":"pipeline","source":"openPR.com","summary":"Emerging Growth Drivers Fueling the Expansion of the Cloud Based Drug Discovery Platform Market - openPR.com","headline":"Emerging Growth Drivers Fueling the Expansion of the Cloud Based Drug Discovery Platform Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNUGU5bXhVa2Z3VFNEOE5kZ0xiRDQxX1ZOZnZPYnRxd25walNpel9yNWdDcUF1ZjhaNnJzNEdDRVhoVVVZdnFITndGYWN0WFFmQ1o4OTg0em1BSTY5WWpxRWducGVOZEFkOGloMDZiT081QzUtTm13Ujd0RXpJMVdYQUE2eTV1U0tkT3o0bzViQWdwQTlqTHc4?oc=5","date":"2026-02-25","type":"pipeline","source":"MedCity News","summary":"Valo Health CEO: We Don’t Want Investors To Drive the Science - MedCity News","headline":"Valo Health CEO: We Don’t Want Investors To Drive the Science","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQNEZadjdjb1lsd29NSFBzVGNwQWZZTFN3X1g4ejJEOVNYbzBEM3drOVZIQUVDNGhsNzNlTndOZmRReVY4cGRReFJhSWZTcDZVYzVPbXFabEtHTU4tNnpqQ0w1Mm5mTGpnREdTMkNtemxHWkVIMGdjd3RhLVMwV0xieVMyYWNKeGJEMUlQcU1YQ0pnaXM?oc=5","date":"2026-02-03","type":"pipeline","source":"Contract Pharma","summary":"Valo Health Names New CSO, Karin Conde-Knape - Contract Pharma","headline":"Valo Health Names New CSO, Karin Conde-Knape","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPaUZTZEdyMmRvazJpOU45ZUZiV1NrUFBCS3NPOXNUd0pCcHo4aUZfR2xSc3JvQktQaWZ0TkVQTlphRzhUc1NVb1BhbE5SVDlQLWhOODVXaEVabWs3aFZjTmNKLW13eDhNbjZmQWN5ei1kVDNDV1B4WFNqSGFuczlnUUJMTQ?oc=5","date":"2025-12-02","type":"pipeline","source":"Contract Pharma","summary":"Valo Health Names Rita Kale CFO - Contract Pharma","headline":"Valo Health Names Rita Kale CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPQjJOYlZTRFdDY1RHZTBDelZBakUzSGtyOEJrUmFQN29DOHM2RzYtd1pBRW1ZUVRCLW85VWNsci1uZjBLdHFha05vVEJaR0I4a1J5YW1rYWJ5QUtjOHZGaXN4Rm1Fc3Mzd1hQek5fNTlpa3l6ejNfekdkd0UzS2kybkt3ZllzUVJ5QnpzNnlGdE5UWlVJRU91MDFkTVd4NU1HRGlnbG5maEZhWW9kbVVZaHl1aG8?oc=5","date":"2025-12-02","type":"pipeline","source":"Business Wire","summary":"Valo Health Appoints Rita Kale as Chief Financial Officer - Business Wire","headline":"Valo Health Appoints Rita Kale as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOSEdPSXFvMzlXbWw5UWdxeHhDR1JCY2kxQ05teGY2TkJmRzZlbmpLUkVaZThEUWdVNzJ1X0dWSEVsQ0NBbElTU1IyUUFSdmtqakFDTkNHdUJVOVBCZjg5c01TNFI3ZDFmQTNJLXBDekphaFJoVy1vaHAycExzRE90UGtTVWlZNEhyeEsxc0lVaVdWUXdKRmlMOTh1SGtnMzc1MXNqNkhkMlYwd3EybWFJVFoyOUx3QnJJZXc?oc=5","date":"2025-11-20","type":"pipeline","source":"Fierce Biotech","summary":"Merck KGaA links up with Flagship's Valo Health in search for Parkinson's targets, offers $3B in biobucks - Fierce Biotech","headline":"Merck KGaA links up with Flagship's Valo Health in search for Parkinson's targets, offers $3B in biobucks","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNTzViUkstSHc1dHA5M29GWjlWM0JSWGFnOFl6eDVxXzNwWklBM2ZJU0l3Q0kzX3hod1dILUVzaXFMSjBVajM5aXZDNFpaQ2hFOVMya1loek5PbnN2MExwMnZ4dEE3RFMwU1R1M0U0LW9sZTBqd0s2by16Uk1UTXZvUm5hMk9XaGNIcWk5RklTNFBiTWdwOHJMeFNJTExDdHRneXR6WDBKaWh1UDI3dUZycE52MDgwLUFXWVc0U3E0dXZFWVhKUnlWUm1sLTRYOEpMU0E?oc=5","date":"2025-11-20","type":"deal","source":"Reuters","summary":"Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal - Reuters","headline":"Merck KGaA to draw on Valo's drug discovery AI in potential $3 billion deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOcGtkYktIdzlWLWt3ZEFGbjNrYUV0STBBMEFhbUlPWFBVV2p6S1RUeFl3ZlhVTXNXc0kzZElTcFNRcjdXT2VBS3BsOFJENExNYXhmRENIQU1fU0owVHktZm5fajJMZkgxTU96bVN0VFlpaXp2bTZQYzUzaFZvcFN3cUtjU2ZJeVdYMlRUc1hEdnJXN1V2NFVlN2k1OVlfN191dkREZzBwRmVIdXVTc0RRN1ozY096TWFDS2ZB?oc=5","date":"2025-11-20","type":"deal","source":"Pharmaceutical Technology","summary":"Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership - Pharmaceutical Technology","headline":"Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOQlA1MjF1RTV5X1RoOVlvMElsdThaT1VlNTQ1TlRVM1RSOFNDWnlhS01XczJ0aDFYam9sVkM3ZTN6RFZUVUstVlR2WDNfWUlYQXNBamtLQ09OX1FtTnV4VFdIUmlQMHZKanhBVWNjUlRtU2g1VFhiLUxDaF91ZElOWHJTWnBxSEJKaHRONFllU1BWQXhHQTlWNC1qcHUwQUE3ZzFsWXVmNA?oc=5","date":"2025-11-20","type":"deal","source":"The Business Journals","summary":"Lexington biotech Valo Health lands deal worth up to $3B with Merck KGaA - The Business Journals","headline":"Lexington biotech Valo Health lands deal worth up to $3B with Merck KGaA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQcUJsYjNSRGdSeGx1Q1F1LWFoU2lJcTJSOUFOcjNUSVQ3N3VtMmtBOWpoWlJoYVJPRkp4S1BfQ1lfUjZxa1JJX2lfeXdiT3liQXF0VkdzNTZIUlZxUEREV3Q2YVNrbHBVMm5kWFZYTkJGSjNYQkFMZTNvVDZHUDM4OHRjMGEtT3NlVWJtUzFSR3lSVXdsR28tcnY3VkxDNEZnajdua3NXWkZXOVVQRFhF?oc=5","date":"2025-11-20","type":"deal","source":"Bloomberg.com","summary":"Merck KGaA, Valo to Use AI for Parkinson’s in $3 Billion Deal - Bloomberg.com","headline":"Merck KGaA, Valo to Use AI for Parkinson’s in $3 Billion Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPOE5IZTFlRFUxTEUzU2xMRlAyb1MyZnltTVd1VHhkdXFiS2NVNUlBcHlIZndXRUJEMVhlc2lHOGVOSU1seTFfQ1k5MHhpTmZiWXZkQVdMTk1LRlBRWFlNZXpwOUY5ak9nMUZQVGZjRW9OeFRGRnVvNUlHQTVwS0V3Vjl2QU96U2xUcnlDQjB5MnFTSkZwaDhvLWEyWC1YemM?oc=5","date":"2025-08-28","type":"pipeline","source":"Fierce Biotech","summary":"Flagship taps IQVIA as biotech support for company fleet - Fierce Biotech","headline":"Flagship taps IQVIA as biotech support for company fleet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBScXRtQ0tnTHAtQ1RNeTQwUm9HcmNXWXVJUzg0NGo4b2dUVnVYSS01ekpBUlpXa1J0bDlpWlhham5ubzhYZXh4dW5yanlVR19ZSnc?oc=5","date":"2025-06-06","type":"trial","source":"Endpoints News","summary":"IPO Tracker (2021) - Endpoints News","headline":"IPO Tracker (2021)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}